Targeted alpha therapy with 212Pb-NNV003 for the treatment of CD37 positive B-cell chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL)
Amal Saidi(Orano (France)), Jostein Dahle(Oslo University Hospital), Astri Fjelde Maaland(University of Oslo), Julien Torgue(Orano (France)), Helèn Heyerdahl(Nordic Nanovector (Norway))
Unknown
May 1, 2019
Cited by 0
Related Papers
DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA
|Photochemistry and Photobiology|1995|181
Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues
|Cancer Letters|1997|68
Fractionated Therapy of HER2-Expressing Breast and Ovarian Cancer Xenografts in Mice with Targeted Alpha Emitting 227Th-DOTA-p-benzyl-trastuzumab
|PLoS ONE|2012|63
<title>Photodynamic therapy with 5-aminoolevulinic acid-induced porphyrins and DMSO/EDTA for basal cell carcinoma</title>
|Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE|1994|60